By James Cavuoto, editor
September 10, 2026 | A team of researchers at Lehigh University has developed one of the first comprehensive mathematical models of the neural circuitry linking the gut and brain, a “digital twin” designed to simulate how bidirectional signaling regulates stomach function. The work, described in Frontiers in Physiology (DOI: /10.3389/fphys.2026.1727491), could help bioelectronic medicine researchers understand disorders of gut-brain interaction and accelerate the development of neuromodulation therapies such as vagus nerve stimulation.
The gut-brain axis has become an increasingly active target for bioelectronic medicine because it connects central autonomic control with digestive function. Signals from the gut help the brain monitor hunger, satiety, and gastric state, while signals from the brain influence digestion in response to stress and other physiological inputs. When this communication loop fails, patients can experience chronic disorders such as irritable bowel syndrome, gastroparesis, and functional dyspepsia.
“The gut-brain axis is a major area of interest in the medical community, but to date, there hasn’t been a clearly defined mathematical model that captures how this communication loop functions quantitatively,” said co-author Mayuresh Kothare, R. L. McCann Professor of Chemical and Biomolecular Engineering and associate dean for research in Lehigh’s P.C. Rossin College of Engineering and Applied Science. “Our work represents one of the first systematic approaches to building a digital twin that allows researchers to simulate that behavior.”
Because the vagus nerve serves as one of the primary communication pathways between the brain and digestive system, it has emerged as a target for neural stimulation therapy. By delivering carefully controlled electrical impulses to activate nerves, researchers hope to restore healthy signaling patterns.
“Our digital twin is like a virtual stomach that helps us understand what happens when signaling is disrupted and why,” said lead author Shannon Fernandes, now a research scientist developing controlled drug delivery systems at AbbVie. “Ultimately, it could help researchers develop more effective neural stimulation therapies.”
From a business perspective, the Lehigh model is significant because it offers a potential preclinical development tool for companies working on closed-loop neuromodulation, implantable stimulation systems, and noninvasive vagus nerve approaches. Rather than relying solely on animal models or early human trials, developers could use a validated computational model to explore stimulation parameters, predict physiological effects, and narrow the design space before expensive experimental work begins.
Lehigh describes the model as a systematic approach to representing the neural communication loop quantitatively. That distinction matters for commercialization: quantitative models can support therapy optimization, regulatory discussions, and reimbursement arguments by helping developers explain why a stimulation protocol should work and how it may be tuned for specific disease states.
The initial focus is gastric function, but the broader opportunity is larger. Disorders of gut-brain interaction affect a substantial share of adults worldwide and remain difficult to treat with conventional drugs. If digital twins can reduce trial-and-error in neuromodulation development, they could become enabling infrastructure for a new class of nervous-system therapies aimed at gastrointestinal disease.
The project also reflects a broader trend in bioelectronic medicine: the convergence of computational physiology, systems engineering, and neural interface design. As the field moves toward more personalized and adaptive stimulation strategies, models that capture patient-relevant physiology may become as important as the stimulation hardware itself.
